Cargando…
Type I Interferon Signature in Chilblain-Like Lesions Associated with the COVID-19 Pandemic
Contemporarily to the new SARS-CoV-2 mediated COVID-19 pandemic, a rise in patients with acral chilblain lesions has been described. They manifest late after mild disease or asymptomatic exposure to SARS-CoV-2. Their pathogenic evolution is currently unknown. In biopsies from three patients with acr...
Autores principales: | Aschoff, Roland, Zimmermann, Nick, Beissert, Stefan, Günther, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768511/ https://www.ncbi.nlm.nih.gov/pubmed/33291622 http://dx.doi.org/10.3390/dermatopathology7030010 |
Ejemplares similares
-
A Novel Type I Interferon Primed Dendritic Cell Subpopulation in TREX1 Mutant Chilblain Lupus Patients
por: Eugster, Anne, et al.
Publicado: (2022) -
Corrigendum: A novel type I interferon primed dendritic cell subpopulation in TREX1 mutant chilblain lupus patients
por: Eugster, Anne, et al.
Publicado: (2022) -
Chilblain-Like Lesions during COVID-19 Pandemic: The State of the Art
por: Bassi, Andrea, et al.
Publicado: (2021) -
A case of antisynthetase syndrome with chilblains‐like lesions and microangiopathy
por: Abrassart, Tom, et al.
Publicado: (2021) -
Elasomeran: Chilblains-like lesions: case report
Publicado: (2022)